Updated:
CORGENIX MEDICAL CORP/CO
CORGENIX MEDICAL CORP/CO is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001063665, and its reported...
Overview
CORGENIX MEDICAL CORP/CO is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001063665, and its reported industry is In Vitro & In Vivo Diagnostic Substances. In 10-K filed on 2014-09-10, it reported annual revenue of USD 11,011,578; net income of USD 371,437; total assets of USD 7,789,446 for the fiscal period ended 2014-06-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- CORGENIX MEDICAL CORP/CO
- Classification
- Company
- Industry (SIC)
- 2835 — In Vitro & In Vivo Diagnostic Substances
- Headquarters
- Broomfield, CO, United States
- Incorporated in
- CO
- Fiscal year end
- June 30
- SEC CIK
- 0001063665
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents |
|---|---|---|---|---|---|
| FY2014USD | $11.0M | $371,437 | $7.8M | $2.4M | |
| FY2013USD | $10.2M | $278,536 | $6.7M | $2.0M | |
| FY2012USD | $9.3M | -$603,702 | $6.3M | $1.2M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research CORGENIX MEDICAL CORP/CO in Altss
Track this company’s investors, transactions and relationships in Altss.